Metastatic renal cell carcinoma: the first report of unilateral fundus hemorrhage induced by sorafenib

BACKGROUND: Renal cell carcinoma (RCC) is the most common type of kidney tumor with increasing incidence. Tyrosine Kinase Inhibitors (TKIs) are considered important treatment in the management of metastatic RCC. Some previous studies demonstrated that sorafenib treatment is associated with a signifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhi Yong, Fan, Xin Xiang, Wang, Yan Jun, Yao, Kai, Liu, Zhuo Wei, Pan, Wen Tao, Ye, Yun Lin, Yang, Ping, Huang, Yi Chuan, Wu, Zhi Ming, Zhou, Fang Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085219/
https://www.ncbi.nlm.nih.gov/pubmed/27174916
http://dx.doi.org/10.18632/oncotarget.9285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085219/
https://www.ncbi.nlm.nih.gov/pubmed/27174916
http://dx.doi.org/10.18632/oncotarget.9285

Ejemplares similares